recess and anterior ethmoid sinus. Currently a transnasal endoscopic approach is used for this, but an external frontoethmoid approach is also safe. Without such a drainage pathway, further complications are very likely to arise from sinusitis sometime in the patient's lifetime.
collapse, visiting physicians offered to help in the confusion that followed. Of course, the heavy casualties did not come, and sadly there was never a need to press volunteer doctors into service. When my conference was over and I was at last allowed to leave on 13 September (New York airports were closed until that date), the return to my infertility practice in Atlanta revealed how far the ripples from those explosions would reach. At our of®ce, bookings for new patient appointments for the remainder of September dropped to 530% of the expected volume. Indeed, in the 10 days immediately after the attacks we registered no new patient appointments at all. Perhaps couples used this time to think about their own present circumstance, rather than to plan for a future baby. Alternatively, for safety reasons they may have decided against¯ying into the world's busiest airport for the required consult in Atlanta. Within 3±4 weeks of 11 September, this low volume had rebounded, and the yearend numbers actually seem to be higher than last year. But why did this happen?
When we attempted to study this patient scheduling behaviour by questionnaire, results were at variance with what we observed directly in clinic. Our centre's internet site, [IVF.com], continued to register heavy traf®c throughout the period corresponding to the terrorist attacks. A poll conducted on that site showed 68% of people`intended to undergo fertility treatment as if 11 September never happened'. It must be admitted, however, that intent and action are not always parallel; clicking a computer button is far easier than spending US $15 000 for an in vitro fertilization cycle. In any case, the putative impact of recent terrorist activity on consumer attitudes to both urgent and elective medical procedures represents a worthy subject for future study.
As one who found myself in Manhattan that historic morning, my helplessness was probably similar to that of witnesses to the Titanic's iceberg collision or the bombing of Pearl Harbor. For Mr Jones and his example of those who were able to help the victims or their loved-ones in New York, Dante's words seem appropriate: E cio Á non fa d'onor poco argomento (Honour not small shall be thy recompense). 
E Scott Sills

More on BSE/vCJD
The expectations of promising treatments described in this update by Dr Beale (December 2001 JRSM 1 ) are offset by his conclusion that`In the long term, unfortunately, there will probably be no shortage of patients in whom to try these treatments'. In saying this, Beale is accepting, without discussion, the conclusion reached by the BSE Inquiry 2 that BSE has caused a harrowing, fatal disease in humans' because they too accept evidence from histopathology, chromatography and experiments in mice that a malfolded prion protein found in the brains of cattle with BSE as proof that it is transmissible to humans in meat and causes variant Creutzfeldt±Jakob disease (vCJD).
This evidence depends entirely upon evidence from laboratories. In the farmyard, dogs, cats and other animals are freely exposed to BSE but, except for rare cases in domestic cats, there is no evidence of comparable encephalopathy. Evidence from national and international surveillance shows no increase in vCJD except in proportion to the increased ascertainment 3,4 which followed identi®cation of cases of CJD in people in younger instead of ageing patients. But this is precisely what Creutzfeldt observed in his ®rst case in 1920, a woman aged 23, which he described in clinical and pathological detail as a unique encephalopathy 5 . Such cases were uncommon because they were identi®ed wrongly (Unter¯asche Flagge) as multiple sclerosis and other neurological disorders which were symptomatically similar but did not show the neuronal degeneration characteristic of the spectrum of encephalopathies subsequently classi®ed as CJD because, although exceedingly rare, they were observed more often in older patients, as described later by Jakob. Similar encephalopathies, occurring notably in sheep as scrapie, in captive and occasionally in various wild mammals are transmissible (TSEs) within and sometime across species barriers by intracerebral trans-inoculations of brain substance. BSE, the latest example, is transmissible by intracerebral or peritoneal inoculation in mice. If the mice are inbred and transgenic, the lesions resulting from intracerebral injection are similar to those of BSE and vCJD.
The surveillance which extended during the two years and nine months of the BSE Inquiry showed that all the patients with vCJD were homozygous for methionine, as are approximately 40% of the resident population of the UK. Although this could indicate a genetic predisposition to form or to accept malfolded PrP, it does not explain why vCJD is so rare in that part of the same population at highest risk of exposure to BSE, namely workers in farms, abattoirs, butchers shops, kitchens and veterinarians.
Among other points escaping attention in Beale's update, as in the Inquiry, is the entire absence of BSE in suckler-then-grass-fed pedigree herds of Herefords, Angus and other breeds except where there is contact with dairy cattle 3 . This suggests that BSE could be a metabolic PrP disease induced by unnatural forced feeding of animal protein to herbivores, with concomitant stress, or by conveyance of mutable strains of scrapie, or because arti®cial insemination from limited pools has created a genetic predisposition in dairy cattle to accommodate the novel mutation from scrapie in 1970 which the Inquiry favours presumptively as the origin of BSE. To say the least, these and other uncertainties cast doubt on Beale's endorsement of the scienti®c prognosis that, among all humans who have ever eaten beef from herds with BSE in or from the UK, there will be (within con®dence limits of zero to in®nity) no shortage of patients who develop a questionably new, ultimately fatal encephalopathy.
